Overview Request Sample Pages Request Customization Download PDF
You are viewing: Netherlands Protein Expression Market analysis
Part of: Protein Expression Market (Global)

The Netherlands Protein Expression Market was valued at $61.2 Million in 2026 and projected to reach to $86.9 Million by 2031, representing a compound annual growth rate of 7.2%. The Netherlands protein expression market is positioned for steady expansion through 2031, supported by the country's established reputation as a life sciences hub and increasing adoption of recombinant protein technologies across pharmaceutical and biotechnology sectors.

Netherlands Protein Expression Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Netherlands Protein Expression Market Trends and Insights

  • Netherlands benefits from a robust biotechnology ecosystem and strong pharmaceutical research infrastructure that drives demand for advanced protein expression technologies.
  • The market in Netherlands is supported by increasing investments in recombinant protein production and growing adoption of expression systems across academic and commercial laboratories. Driving growth in Netherlands is the rising prevalence of chronic diseases requiring protein-based therapeutics and diagnostics.
  • Netherlands has emerged as a key hub for biopharmaceutical development in Europe, with numerous contract research organizations and biotech firms leveraging protein expression platforms.
  • Between 2026 and 2031, Netherlands will experience accelerating demand for mammalian and microbial expression systems, particularly in monoclonal antibody and vaccine production. The competitive landscape in Netherlands features both established multinational suppliers and innovative local players.
  • Netherlands continues to attract significant R&D investment in synthetic biology and protein engineering, positioning the country as a strategic market for expression technology providers seeking European expansion..

Key Market Statistics

  • CAGR (2026-2031) 7.2% CAGR
  • Market Size, 2026 ~USD 61.2 Million
  • Forecast, 2031 ~USD 86.9 Million
  • Country Netherlands

Netherlands Protein Expression Market Overview

Market Valuation :

The Netherlands protein expression market is valued at $61.2 million in 2026 and is projected to reach $86.9 million by 2031, demonstrating strong growth potential in this specialized biotechnology segment.

Growth Trajectory :

With a CAGR of 7.2% through 2031, the Netherlands market is growing faster than many European counterparts, driven by increasing investments in biopharmaceutical research and development activities.

Biotechnology Ecosystem :

The Netherlands hosts a robust biotechnology ecosystem with world-class research institutions, including leading universities and biotech clusters in Amsterdam, Utrecht, and Leiden that drive innovation in protein expression technologies.

Pharmaceutical Infrastructure :

Strong pharmaceutical research infrastructure and presence of major contract research organizations (CROs) in the Netherlands create sustained demand for advanced protein expression solutions and services.

Netherlands Protein Expression Market Dynamics

  • The market benefits from significant government support for biotech innovation, strategic partnerships between academic institutions and industry players, and growing demand for personalized medicine solutions.
  • Key drivers include expansion of biopharmaceutical manufacturing capabilities, rising investment in monoclonal antibody development, and increasing outsourcing of protein expression services to specialized providers.
  • The competitive landscape remains dynamic with both established players and emerging biotech companies contributing to market growth..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Netherlands protein expression market grows from $61.2M (2026) to $86.9M (2031) at 7.2% CAGR
    • Netherlands is a leading European hub for biopharmaceutical research and recombinant protein production
    • Mammalian and microbial expression systems dominate demand in Netherlands through 2031
    • Netherlands attracts significant biotech investment, supporting sustained market expansion

    Protein Expression Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment SOFTWARE (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.3% from 2026 to 2031
    Largest Segment PRODUCTS (Offering)
    Market Size Base Year (Billions) ~USD 5.13 (2026)
    Revenue Forecast (Billions) ~USD 7.65 (2031)
    Segments Covered Offering, Type, End User, Workflow, Scale Of Operation, Protein Modality, Application

    Netherlands Protein Expression Market Report Segmentation

    7 segment dimensions are covered across the global market.

    By Offering

    • Products
    • Services

    By Type

    • Algal & Plant-Based Expression Systems
    • Algal-Based Expression Systems
    • Analytical Instruments
    • Bacillus Systems
    • Baculovirus Systems
    • Bioreactors & Fermenters
    • Cell-Free Expression Systems
    • Cho Cell Systems
    • Chromatography & Purification Consumables
    • Chromatography Systems
    • Cld Services
    • Cloning & Mutagenesis Kits
    • Competent Cells
    • Consumables
    • Culture Media & Supplements
    • Custom Protein Expression Services
    • E. Coli Lysate-Based Systems
    • E. Coli Systems
    • Expression Kits
    • Expression Vectors & Plasmids
    • Filtration & Separation Consumables
    • Filtration Systems
    • Gene Synthesis & Cloning Services
    • Hek 293 Cell Systems
    • Insect Cell Expression Systems
    • Instruments
    • Kits
    • Liquid Handling & Automation Systems
    • Mammalian Cell Expression Systems
    • Other Cell-Free Expression Systems
    • Other Consumables
    • Other Insect Cell Expression Systems
    • Other Instruments
    • Other Kits
    • Other Mammalian Cell Expression Systems
    • Other Prokaryotic Expression Systems
    • Other Reagents
    • Other Yeast Expression Systems
    • Pichia Systems
    • Process Development & Scale-Up Services
    • Prokaryotic Expression Systems
    • Reagents
    • Saccharomyces Systems
    • Software
    • Transduction & Transfection Reagents
    • Yeast Expression Systems

    By End User

    • Academic & Research Institutes
    • Cros & Cdmos
    • Other End Users
    • Pharmaceutical & Biotechnology Companies

    By Workflow

    • Cloning & Transfection
    • Extraction, Purification, And Characterization
    • Transcription, Translation, And Post-Translational Modification (Ptm)

    By Scale Of Operation

    • Discovery & Research Scale
    • Preclinical & Characterization Scale
    • Process Development & Pilot Scale

    By Protein Modality

    • Enzymes & Catalytic Proteins
    • Monoclonal Antibodies & Derivatives
    • Other Proteins
    • Recombinant Therapeutic Proteins
    • Vaccines

    By Application

    • Diagnostic Applications
    • Industrial Applications
    • Research Applications
    • Therapeutic Applications

    NETHERLANDS: PROTEIN EXPRESSION PRODUCTS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES12.412.814.115.216.417.61920.47.7
    CROS & CDMOS14.114.51617.418.720.321.923.68
    OTHER END USERS10.210.411.211.912.513.31414.85.7
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES17.718.219.921.322.824.526.2287.1
    TOTAL54.555.961.265.870.575.781.186.97.2

    NETHERLANDS: PROTEIN EXPRESSION SERVICES MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES3.843.964.364.75.075.475.896.347.8
    OTHER END USERS1.031.041.121.191.251.321.41.475.6
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES7.247.448.178.89.4610.1810.9411.757.5
    TOTAL12.112.4413.6514.6915.7816.9718.2319.567.5

    Target Audience

    • Biopharmaceutical Companies : Dutch and international pharma firms need Netherlands-specific market data to assess local demand for protein expression services, identify partnership opportunities, and plan manufacturing or R&D investments in the region.
    • Contract Research Organizations : CROs operating in or targeting the Netherlands require detailed market intelligence to benchmark service offerings, understand customer requirements, and identify growth opportunities in protein expression outsourcing.
    • Biotech Equipment Manufacturers : Suppliers of protein expression systems and reagents need Netherlands market insights to tailor product development, identify key customer segments, and optimize sales strategies for this specialized market.
    • Investment & Venture Capital Firms : Investors evaluating biotech opportunities in the Netherlands need market-specific data to assess growth potential, competitive dynamics, and funding landscape for protein expression technology companies.
    • Academic & Research Institutions : Dutch universities and research centers require market data to understand commercialization opportunities, identify industry partnerships, and align research initiatives with market demand for protein expression innovations.

    Key Companies in the Netherlands Protein Expression Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug Product Services (finished dosage manufacturing & packaging),Pharmaceutical Development Services,Drug Substance Services (small- and large-molecule APIs),
    NANOSTRING TECHNOLOGIES, INCUnited StatesPrivate CompanynCounter instruments and consumables (Pro, FLEX, SPRINT, CodeSets, panels, reagents),GeoMx DSP and spatial biology solutions,Prosigna and other in vitro diagnostic kits,
    BIOGENUnited StatesPublic CompanyMultiple Sclerosis therapies (TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, OCREVUS-related),SPINRAZA and rare neuromuscular (SPINRAZA, QALSODY, SKYCLARYS),Alzheimer’s and neuropsychiatry (LEQEMBI, ZURZUVAE),
    SIGMA-ALDRICH CORPORATIONUnited StatesPrivate CompanyPharma and biopharma manufacturing (media, filtration, critical raw materials, safety testing),Research reagents and molecular biology (chemicals, biochemicals, functional genomics, protein biology),Analytical chemistry, diagnostics, and industrial microbiology,
    VIVA BIOTECH LTDChinaPublic CompanyDiscovery biology & structural biology services,Medicinal and synthetic chemistry & CADD,CDMO & CMC/filing services,
    CODEXIS, INC.United StatesPublic CompanyBiopharma process enzymes and custom engineering (CodeEvolver-based),ECO Synthesis and nucleic acid manufacturing solutions,Other life science and industrial enzyme applications,
    MAXCYTE, INCUnited StatesPublic CompanyExPERT ATx instruments and related consumables,ExPERT STx instruments and related consumables,ExPERT GTx instruments and related consumables,
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    MERCK KGAAGermanyPublic CompanyLife Science (reagents, consumables, bioprocessing, CDMO),Healthcare (oncology, neurology, fertility, rare diseases),Electronics (semiconductor and display materials, delivery equipment),
    DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing and bioproduction),Life Sciences (research and analytical instruments, genomics),Diagnostics (clinical instruments and consumables),
    AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
    SARTORIUS AGGermanyPublic CompanyBioprocess solutions (bioreactors, cell culture, fluid management, process filtration),Analytical solutions (BLI, cytometry screening, PAT, live-cell imaging, SPR),Lab products and services (filtration, purification, lab water, weighing, pipettes, microbiological testing),
    GENSCRIPTHong KongPublic CompanyLife Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products,
    TAKARA BIO INC.JapanPrivate CompanyGenetic and cellular research reagents,Instruments and cellular analysis devices,In vitro diagnostics (including COVID-19),
    BIO-RAD LABORATORIES, INC.United StatesPublic CompanyClinical Diagnostics,Life Science Research Instruments and Reagents,Other / Software and Services,
    QIAGENNetherlandsPublic CompanySample technologies (extraction and purification consumables/instruments),PCR and enzymes (qPCR/dPCR instruments and reagents),Molecular diagnostic assays (TB, oncology, sexual and reproductive health, transplant/viral load),
    CHARLES RIVER LABORATORIESUnited StatesPublic CompanyResearch Models and Services,Discovery and Safety Assessment,Manufacturing Solutions,
    CORNING INCORPORATEDUnited StatesPublic CompanyOptical communications (fiber, cable, hardware, equipment),Display glass substrates (LCD/OLED),Specialty materials and mobile consumer electronics glass,
    LONZASwitzerlandPublic CompanyIntegrated Biologics (mammalian and drug product CDMO),Advanced Synthesis (small molecules, HPAPIs, ADCs, bioconjugates),Specialized Modalities (cell & gene, microbial, bioscience, mRNA),
    FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, image sensors, functional films, storage),Business Innovation (office equipment, document services, graphic communications),
    SYNGENE INTERNATIONAL LIMITEDIndiaPublic CompanyDiscovery Services (chemistry, biology, computational),Development Services (preclinical, CMC, clinical development),Biologics and Specialty Modalities,
    LGC LIMITEDSouth KoreaPublic CompanyEthylene-based synthetic resins (PE, EVA, LLDPE, UNIQABLE),Styrene-based resins (ABS, ASA, PS, EPS, SAN),Polycarbonate and engineering plastics (LUMID/LUXY, LUMILOY, LUPOL, LUPOY, etc.),

    PATHEON INC

    Patheon Inc is a Netherlands-based private company with 9,100 employees operating in the life sciences sector.

    NANOSTRING TECHNOLOGIES, INC

    NanoString Technologies, Inc is a United States-based private company founded in 2003 with 550 employees specializing in life sciences technology.

    BIOGEN

    Biogen is a United States-based public company founded in 1978 with 7,500 employees engaged in biotechnology and pharmaceutical development.

    SIGMA-ALDRICH CORPORATION

    Sigma-Aldrich Corporation is a United States-based private company founded in 1951 with 9,800 employees providing life sciences products and services.

    VIVA BIOTECH LTD

    Viva Biotech Ltd is a China-based public company founded in 2008 with 2,169 employees providing drug discovery and development services.

    CODEXIS, INC.

    Codexis, Inc is a United States-based public company founded in 2002 with 146 employees focused on enzyme engineering and biocatalysis.

    MAXCYTE, INC

    MaxCyte, Inc is a United States-based public company founded in 1998 with 91 employees specializing in cell engineering technology.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc is a United States-based public company founded in 1956 with 125,000 employees serving the life sciences and laboratory sectors globally.

    MERCK KGAA

    Merck KGaA is a Germany-based public company founded in 1668 with 59,077 employees operating as a diversified pharmaceutical and chemical company.

    DANAHER CORPORATION

    Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees engaged in life sciences, diagnostics, and environmental solutions.

    AGILENT TECHNOLOGIES, INC.

    Agilent Technologies, Inc is a United States-based public company founded in 1999 with 18,000 employees providing analytical instruments and life sciences solutions.

    SARTORIUS AG

    Sartorius AG is a Germany-based public company founded in 1870 with 14,242 employees specializing in laboratory and bioprocess equipment.

    GENSCRIPT

    GenScript is a Hong Kong-based public company founded in 2002 with 6,165 employees providing biotechnology research services and products.

    TAKARA BIO INC.

    Takara Bio Inc is a Japan-based private company founded in 2002 with 1,779 employees specializing in biotechnology research tools and services.

    BIO-RAD LABORATORIES, INC.

    Bio-Rad Laboratories, Inc is a United States-based public company founded in 1952 with 7,450 employees manufacturing life sciences research and clinical diagnostics products.

    QIAGEN

    Qiagen is a Netherlands-based public company founded in 1984 with 5,500 employees providing molecular diagnostics and life sciences research solutions.

    CHARLES RIVER LABORATORIES

    Charles River Laboratories is a United States-based public company founded in 1947 with 19,000 employees providing preclinical and clinical laboratory services.

    CORNING INCORPORATED

    Corning Incorporated is a United States-based public company founded in 1851 with 67,200 employees manufacturing specialty glass and materials for life sciences applications.

    LONZA

    Lonza is a Switzerland-based public company founded in 1897 with 20,000 employees providing pharmaceutical and biotechnology manufacturing services.

    FUJIFILM HOLDINGS CORPORATION

    Fujifilm Holdings Corporation is a Japan-based public company founded in 1934 with 73,526 employees operating across imaging, pharmaceuticals, and life sciences sectors.

    SYNGENE INTERNATIONAL LIMITED

    Syngene International Limited is an India-based public company founded in 1993 with 6,692 employees providing drug discovery and development services.

    LGC LIMITED

    LGC Limited is a South Korea-based public company founded in 1947 with 14,019 employees operating in life sciences and analytical testing services.

    Reasons to Buy this Report

    • Market-Specific Sizing : Obtain precise valuation data for the Netherlands protein expression market with detailed 2026-2031 forecasts, enabling accurate budget allocation and investment planning specific to this high-growth European market.
    • Competitive Intelligence : Understand the competitive landscape unique to the Netherlands, including key players, market consolidation trends, and strategic partnerships within the Dutch biotechnology and pharmaceutical sectors.
    • Regional Growth Drivers : Identify Netherlands-specific growth catalysts including government biotech initiatives, university-industry collaborations, and infrastructure developments that differentiate this market from broader European trends.
    • Investment Opportunity Assessment : Evaluate expansion opportunities in the Netherlands market with insights into emerging biotech clusters, CRO capabilities, and demand patterns for protein expression technologies and services.
    • Strategic Market Entry : Develop targeted go-to-market strategies for the Netherlands with localized insights on regulatory environment, customer preferences, and distribution channels specific to Dutch pharmaceutical and biotech organizations.

    Frequently asked questions

    What is the current size of the protein expression market in Netherlands?

    The Netherlands protein expression market is valued at $61.2 million in 2026 and is expected to reach $86.9 million by 2031.

    What is the projected growth rate for protein expression in Netherlands?

    The Netherlands protein expression market is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2031.

    Why is Netherlands a key market for protein expression technologies?

    Netherlands has a strong biotechnology ecosystem, robust pharmaceutical research infrastructure, and is home to numerous contract research organizations and biotech firms that drive demand for protein expression platforms.

    Which expression systems are most in demand in Netherlands?

    Mammalian and microbial expression systems are the dominant technologies in Netherlands, particularly for monoclonal antibody and vaccine production applications.

    What factors are driving growth in the Netherlands protein expression market?

    Key growth drivers include rising prevalence of chronic diseases, increasing investments in recombinant protein production, growing adoption of expression systems in research, and Netherlands' position as a European biopharmaceutical hub.

    RESEARCH METHODOLOGY

    This study involved four major activities in estimating the current size of the protein expression market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.

    Secondary Research

    Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Food and Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceutical Research and Manufacturers of America (PhRMA), Global Cancer Observatory (GLOBOCAN), Centers for Disease Control and Prevention (CDC), and European Federation of Biotechnology,. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global protein expression market, and the findings were validated through primary research.

    Primary Research

    In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Protein Expression Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The global size of the protein expression market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Protein Expression Market : Top-Down and Bottom-Up Approach

    Protein Expression Market Top Down and Bottom Up Approach

    Data Triangulation

    After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.

    Market Definition

    The protein expression market encompasses the technologies, products, and services required for protein production and analysis. This market includes various expression systems (mammalian, bacterial, yeast, algal, insect, and cell-free), reagents and instruments for transfection and cloning, growth reagents for cell culture during translation, and reagents and kits for downstream processes such as purification and characterization. It serves industries such as pharmaceuticals, biotechnology, academic & research institutes, CROs & CDMOs, and other industrial users, supporting applications in drug discovery, therapeutic development, and biochemical research, as well as other industries such as food and beverages, cosmetics, and textiles, among others.

    Key Stakeholders

    • Protein Expression Instrument & Reagent Manufacturers
    • Suppliers of Expression Systems
    • National and regional research boards and organizations
    • Research & development companies
    • Clinical research organizations (CROs)
    • Contract Manufacturing Organizations (CMOs)
    • Biotechnology companies
    • Research laboratories & academic institutes
    • Market research & consulting firms
    • Regulatory bodies

    Report Objectives

    • To define, describe, and forecast the protein expression market by offering, type, workflow, scale of operation, protein modality, application, product end user, service end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall protein expression market
    • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC (Saudi Arabia, United Arab Emirates, and the Rest of GCC) and the Rest of Middle East], and Africa
    • To profile the key players and analyze their market shares and core competencies
    • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
    • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

    Customization Options

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe protein expression market, by country
    • Further breakdown of the Rest of Asia Pacific protein expression market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Cross-segment analysis

    Get the Full Protein Expression Market Report

    Full forecast, segment splits, and company analysis for all Protein Expression Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status